Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309336423> ?p ?o ?g. }
- W4309336423 endingPage "971" @default.
- W4309336423 startingPage "958" @default.
- W4309336423 abstract "The purpose of this study was to compare the outcomes of primary reverse total shoulder arthroplasty (rTSA) using glenoid bone grafting (BG rTSA) with primary rTSA using augmented glenoid baseplates (Aug rTSA) with a minimum 2-year follow-up.A total of 520 primary rTSA patients treated with 8° posterior glenoid augments (n = 246), 10° superior glenoid augments (n = 97), or combined 10° superior/8° posterior glenoid augments (n = 177) were compared with 47 patients undergoing glenoid bone grafting for glenoid bone insufficiency. The mean follow-up was 37.0(±16) and 53.0(±27) months, respectively. Outcomes were analyzed preoperatively and at the latest follow-up using conventional statistics and stratification by minimum clinically important difference (MCID) and substantial clinical benefit (SCB) thresholds where applicable. Radiographs were analyzed for baseplate failure, and the incidences of postoperative complications and revisions were recorded.The glenoid Aug rTSA cohort had greater improvements in patient-reported outcome measures (PROMs) and range of motion when compared with the BG rTSA group at a minimum of 2-year follow-up, including Simple Shoulder Test, Constant score, American Shoulder and Elbow Surgeons score, University of California Los Angeles score, Shoulder Pain and Disability Index score, shoulder function, Shoulder Arthroplasty Smart score, abduction, and external rotation (P < .05). Patient satisfaction was higher in the Aug rTSA group compared with the BG rTSA group (P = .006). The utilization of an augmented glenoid component instead of glenoid bone grafting resulted in approximately 50% less total intraoperative time (P < .001), nearly 33% less intraoperative blood loss volume (P < .001), approximately 3-fold less scapular notching (P < .01), and approximately 8-fold less adverse events requiring revision (P < .01) when compared with the BG rTSA cohort. Aside from SCB for abduction, the Aug rTSA cohort achieved higher rates of exceeding MCID and SCB for every PROM compared with BG rTSA. More specifically, 77.6% and 70.2% of the Aug rTSA achieved SCB for American Shoulder and Elbow Surgeons and Shoulder Pain and Disability Index vs. 55% and 48.6% in the BG rTSA, respectively (P = .003 and P = .013).The present midterm clinical and radiographic study demonstrates that the utilization of an augmented baseplate for insufficient glenoid bone stock is superior as judged by multiple PROMs and range of motion metrics when compared with bone graft augmentation at minimum 2-year follow-up. In addition, when analyzed according to MCID and SCB thresholds, the use of augmented baseplates outperforms the use of glenoid bone grafting. Complication and revision rates also favor the use of augmented glenoid baseplates over glenoid bone grafting. Long-term clinical and radiographic follow-up is necessary to confirm that these promising midterm results are durable." @default.
- W4309336423 created "2022-11-26" @default.
- W4309336423 creator A5021464031 @default.
- W4309336423 creator A5027289785 @default.
- W4309336423 creator A5030296966 @default.
- W4309336423 creator A5031335754 @default.
- W4309336423 creator A5039688005 @default.
- W4309336423 creator A5046788049 @default.
- W4309336423 creator A5047261499 @default.
- W4309336423 creator A5069892187 @default.
- W4309336423 creator A5077149893 @default.
- W4309336423 creator A5090428346 @default.
- W4309336423 date "2023-05-01" @default.
- W4309336423 modified "2023-09-30" @default.
- W4309336423 title "Augmented baseplates yield optimum outcomes when compared with bone graft augmentation for managing glenoid deformity during reverse total shoulder arthroplasty: a retrospective comparative study" @default.
- W4309336423 cites W147634606 @default.
- W4309336423 cites W1970044003 @default.
- W4309336423 cites W1981078418 @default.
- W4309336423 cites W1986494589 @default.
- W4309336423 cites W1991244147 @default.
- W4309336423 cites W2001496935 @default.
- W4309336423 cites W2008976221 @default.
- W4309336423 cites W2019906210 @default.
- W4309336423 cites W2026207814 @default.
- W4309336423 cites W2057527053 @default.
- W4309336423 cites W2108703455 @default.
- W4309336423 cites W2150911326 @default.
- W4309336423 cites W2164133735 @default.
- W4309336423 cites W2253053130 @default.
- W4309336423 cites W2759214487 @default.
- W4309336423 cites W2770617653 @default.
- W4309336423 cites W2793965617 @default.
- W4309336423 cites W2899043307 @default.
- W4309336423 cites W2992608781 @default.
- W4309336423 cites W3005899089 @default.
- W4309336423 cites W3033280386 @default.
- W4309336423 cites W3047365536 @default.
- W4309336423 cites W3092450120 @default.
- W4309336423 cites W3126996659 @default.
- W4309336423 cites W3131872319 @default.
- W4309336423 cites W4249111912 @default.
- W4309336423 doi "https://doi.org/10.1016/j.jse.2022.10.015" @default.
- W4309336423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36400341" @default.
- W4309336423 hasPublicationYear "2023" @default.
- W4309336423 type Work @default.
- W4309336423 citedByCount "1" @default.
- W4309336423 countsByYear W43093364232023 @default.
- W4309336423 crossrefType "journal-article" @default.
- W4309336423 hasAuthorship W4309336423A5021464031 @default.
- W4309336423 hasAuthorship W4309336423A5027289785 @default.
- W4309336423 hasAuthorship W4309336423A5030296966 @default.
- W4309336423 hasAuthorship W4309336423A5031335754 @default.
- W4309336423 hasAuthorship W4309336423A5039688005 @default.
- W4309336423 hasAuthorship W4309336423A5046788049 @default.
- W4309336423 hasAuthorship W4309336423A5047261499 @default.
- W4309336423 hasAuthorship W4309336423A5069892187 @default.
- W4309336423 hasAuthorship W4309336423A5077149893 @default.
- W4309336423 hasAuthorship W4309336423A5090428346 @default.
- W4309336423 hasConcept C111278954 @default.
- W4309336423 hasConcept C141071460 @default.
- W4309336423 hasConcept C142724271 @default.
- W4309336423 hasConcept C167135981 @default.
- W4309336423 hasConcept C168563851 @default.
- W4309336423 hasConcept C204787440 @default.
- W4309336423 hasConcept C2776164576 @default.
- W4309336423 hasConcept C2776337968 @default.
- W4309336423 hasConcept C2778336525 @default.
- W4309336423 hasConcept C2779777117 @default.
- W4309336423 hasConcept C2779982284 @default.
- W4309336423 hasConcept C2781184374 @default.
- W4309336423 hasConcept C36454342 @default.
- W4309336423 hasConcept C60465272 @default.
- W4309336423 hasConcept C71924100 @default.
- W4309336423 hasConceptScore W4309336423C111278954 @default.
- W4309336423 hasConceptScore W4309336423C141071460 @default.
- W4309336423 hasConceptScore W4309336423C142724271 @default.
- W4309336423 hasConceptScore W4309336423C167135981 @default.
- W4309336423 hasConceptScore W4309336423C168563851 @default.
- W4309336423 hasConceptScore W4309336423C204787440 @default.
- W4309336423 hasConceptScore W4309336423C2776164576 @default.
- W4309336423 hasConceptScore W4309336423C2776337968 @default.
- W4309336423 hasConceptScore W4309336423C2778336525 @default.
- W4309336423 hasConceptScore W4309336423C2779777117 @default.
- W4309336423 hasConceptScore W4309336423C2779982284 @default.
- W4309336423 hasConceptScore W4309336423C2781184374 @default.
- W4309336423 hasConceptScore W4309336423C36454342 @default.
- W4309336423 hasConceptScore W4309336423C60465272 @default.
- W4309336423 hasConceptScore W4309336423C71924100 @default.
- W4309336423 hasIssue "5" @default.
- W4309336423 hasLocation W43093364231 @default.
- W4309336423 hasLocation W43093364232 @default.
- W4309336423 hasOpenAccess W4309336423 @default.
- W4309336423 hasPrimaryLocation W43093364231 @default.
- W4309336423 hasRelatedWork W1524907207 @default.
- W4309336423 hasRelatedWork W2017889386 @default.
- W4309336423 hasRelatedWork W2090155968 @default.
- W4309336423 hasRelatedWork W2396223989 @default.
- W4309336423 hasRelatedWork W2606558853 @default.